Algo version: 0.98b
OncoZenge AB (publ) is listed at the STO Exchange
OncoZenge AB (publ) [ONCOZ.ST]
STO Sector: Healthcare Industry:Biotechnology

Is OncoZenge AB (publ) stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for OncoZenge AB (publ) 10 years ago, but if you had invested on Friday 12th of February 2021 when the price was SEK12.24, you would have made a loss of SEK-6.06 per share or -49.50%

No, the average daily trading liquidity for OncoZenge AB (publ) is SEK44 210 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

OncoZenge AB (publ) has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for OncoZenge AB (publ) to be medium [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.